EarlySense – Medical Device Firm – Raises $3 Million From The Challenge Fund And ProSeed Venture Capital

RAMAT GAN, Israel--(BUSINESS WIRE)--“EarlySense”, an Israeli company developing a monitoring system for the improved care of Asthma, COPD and Congestive Heart Failure patients, has announced today the closing of a $3 Million second round of financing. This round was led by the Etgar Challenge Fund joined by the ProSeed Venture Capital Fund private investors. To date, the company had raised about $1.25 Million U.S. Dollars in two rounds: the seed round in 2004 from private investors and a first round from the Challenge Fund in 2005.